Skip to main content
Top
Published in: Journal of Nephrology 6/2021

01-12-2021 | Glomerulonephritis | Lessons for the Clinical Nephrologist

Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era

Authors: Vincenzo L’Imperio, Antonella Barreca, Barbara Vergani, Renato Alberto Sinico, Fabio Pagni

Published in: Journal of Nephrology | Issue 6/2021

Login to get access

Excerpt

A 56-year-old man with arterial hypertension, previous history of melanoma with negative follow-up and benign prostatic hyperplasia presented with scrotal edema, subnephrotic proteinuria (2.1 g/die) and microhematuria with an initial decrease in renal function (serum creatinine 1.4 mg/dl). Physical examination and ultrasound showed varicocele as a possible cause of the edema, but further laboratory tests revealed hypocomplementemia (C3 20 mg/dl and C4 3 mg/dl) with negative autoimmunity and viral markers. Renal biopsy showed a glomerulocentric deposition of hyaline, acellular, amorphous material occupying mesangial areas and capillary walls, with slight positivity to PAS stain (Fig. 1a) and negativity to Jones silver stain (Fig. 1b). No vascular nor tubulointerstitial involvement by these deposits was noted. Immunofluorescence on snap-frozen tissue was positive for IgG, with clear cut lambda light chain restriction (Fig. 1c, d).
Literature
1.
go back to reference Leung N, Bridoux F, Hutchison CA et al (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120:4292–4295CrossRef Leung N, Bridoux F, Hutchison CA et al (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120:4292–4295CrossRef
2.
go back to reference Iskandar SS, Falk RJ, Jennette JC (1992) Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 42:1401–1407CrossRef Iskandar SS, Falk RJ, Jennette JC (1992) Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 42:1401–1407CrossRef
3.
go back to reference Nasr SH, Valeri AM, Cornell LD et al (2011) Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol 6:775–784CrossRef Nasr SH, Valeri AM, Cornell LD et al (2011) Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol 6:775–784CrossRef
4.
go back to reference Leung N, Bridoux F, Batuman V et al (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45–59CrossRef Leung N, Bridoux F, Batuman V et al (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45–59CrossRef
6.
go back to reference Nasr SH, Vrana JA, Dasari S et al (2018) DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep 3:56–64CrossRef Nasr SH, Vrana JA, Dasari S et al (2018) DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep 3:56–64CrossRef
7.
go back to reference Nasr SH, Sirac C, Bridoux F et al (2019) Heavy chain fibrillary glomerulonephritis: a case report. Am J Kidney Dis 74:276–280CrossRef Nasr SH, Sirac C, Bridoux F et al (2019) Heavy chain fibrillary glomerulonephritis: a case report. Am J Kidney Dis 74:276–280CrossRef
8.
go back to reference Said SM, Leung N, Alexander MP et al (2020) DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. Kidney Int 98:498–504CrossRef Said SM, Leung N, Alexander MP et al (2020) DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. Kidney Int 98:498–504CrossRef
9.
go back to reference Kudose S, Canetta P, Andeen NK et al (2021) Diagnostic approach to glomerulonephritis with fibrillar IgG deposits and light chain restriction. Kidney Int Rep 6:936–945CrossRef Kudose S, Canetta P, Andeen NK et al (2021) Diagnostic approach to glomerulonephritis with fibrillar IgG deposits and light chain restriction. Kidney Int Rep 6:936–945CrossRef
Metadata
Title
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era
Authors
Vincenzo L’Imperio
Antonella Barreca
Barbara Vergani
Renato Alberto Sinico
Fabio Pagni
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 6/2021
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-021-01053-7

Other articles of this Issue 6/2021

Journal of Nephrology 6/2021 Go to the issue

Lessons for the Clinical Nephrologist

A case of severe hypophosphatemia

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine